 SOUTH SAN FRANCISCO, Calif.--BUSINESS WIRE-- DNA--Twist Bioscience Corporation NASDAQ: TWST, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, a leading commercial next-generation sequencing NGS provider in China, will add Twists NGS target enrichment and library preparation tools to its offering. The product offering combines the genomic and next generation sequencing expertise of Berry G 